why choose us

First received: September 24, 2024

Clinical Trial: A Phase 1 Dose Escalation Study of VX-973 in Healthy Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Pain

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-blind, Placebo-controlled, Single- and Multiple-dose Escalation Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of VX-973 in Healthy Adults

Brief Summary: The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of VX-973 in healthy participants.

Read more